AVRO Market Cap History



Below is a table of the AVRO market cap history going back to 6/21/2018:

Date AVRO Market Cap
6/21/2018696.19M
7/31/2018765.98M
11/8/2018722.03M
3/20/2019448.50M
5/9/2019473.28M
8/5/2019591.79M
8/8/2019674.63M
11/5/2019457.92M
3/6/2020735.74M
4/30/2020463.78M
7/31/2020617.70M
10/30/2020520.52M
3/9/2021510.29M
5/6/2021365.45M
7/30/2021321.07M
10/29/2021245.33M
3/10/202263.36M
5/3/202238.89M
8/2/202240.27M
11/1/202230.64M
3/16/202354.67M
5/4/202329.11M
8/3/202367.69M
11/2/202369.98M

Also see: AVRO Shares Outstanding History
and AVRO YTD Return
AVRO Historical Market Cap:
-34.81% CAGR
AVRO Historical Market Cap: +-34.81% CAGR

Mouse over chart for data details
6/21/2018 ...11/2/2023
AVROBIO is a clinical-stage gene therapy company focused on developing potentially curative ex vivo lentiviral gene therapies to treat patients with rare diseases following a single dose treatment regimen. Co.'s gene therapies employ hematopoietic stem cells (HSC) that are harvested from the patient and then modified with a lentiviral vector to insert the functional copy of the gene that is mutated in the target disease. Co. has four HSC gene therapy programs: VR-RD-02 for the treatment of Gaucher disease type 1 and type 3; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of neuronopathic mucopolysaccharidosis type II; and AVR-RD-03 for the treatment of Pompe disease. We show 24 historical shares outstanding datapoints in our AVRO shares outstanding history coverage, used to compute AVRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AVRO market cap history over the course of time is important for investors interested in comparing AVRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AVRO versus a peer is one thing; comparing AVRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AVRO can fluctuate over the course of history. With this page we aim to empower investors researching AVRO by allowing them to research the AVRO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AVRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AVROBIO (AVRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AVTE Market Cap History
AVTX Market Cap History
AVXL Market Cap History
AWH Market Cap History
AXDX Market Cap History
AXGN Market Cap History
AXGT Market Cap History
AXLA Market Cap History
AXNX Market Cap History
AXSM Market Cap History
More Healthcare companies »

 

AVRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.